[1] |
LI X, TANG X, LU J, et al. Therapeutic inhibition of galectin3 improves cardiomyocyte apoptosis and survival during heart failure[J]. Mol Med Rep, 2018, 17(3):4106-4112.
|
[2] |
GAO Z, LIU Z, WANG R, et al. Galectin-3 is a potential mediator for atherosclerosis[J]. J Immunol Res, 2020, 2020:5284728.
|
[3] |
WHAYNE T F. Low-density lipoprotein cholesterol (LDL-C):how low?[J]. Curr Vasc Pharmacol, 2017, 15(4):374-379.
|
[4] |
PEI C, ZHANG Y, WANG P, et al. Berberine alleviates oxidized low-density lipoprotein-induced macrophage activation by downregulating galectin-3 via the NF-κB and AMPK signaling pathways[J]. Phytother Res, 2019, 33(2):294-308.
DOI
PMID
|
[5] |
CHEN X, LIN J, HU T, et al. Galectin-3 exacerbates ox-LDL-mediated endothelial injury by inducing inflammation via integrin β1-RhoA-JNK signaling activation[J]. J Cell Physiol, 2019, 234(7):10990-11000.
DOI
PMID
|
[6] |
OU H C, CHOU W C, HUNG C H, et al. Galectin-3 aggravates ox-LDL-induced endothelial dysfunction through LOX-1 mediated signaling pathway[J]. Environ Toxicol, 2019, 34(7):825-835.
DOI
URL
|
[7] |
ZHANG P, SU Q, YE X, et al. Trends in LDL-C and non-HDL-C levels with age[J]. Aging Dis, 2020, 11(5):1046-1057.
DOI
|
[8] |
诸骏仁, 高润霖, 赵水平, 等. 中国成人血脂异常防治指南(2016年修订版)[J]. 中华健康管理学杂志, 2017, 11(1):7-28.
|
[9] |
中华医学会心血管病学分会心力衰竭学组, 中国医师协会心力衰竭专业委员会, 中华心血管病杂志编辑委员会. 中国心力衰竭诊断和治疗指南2018[J]. 中华心血管病杂志, 2018, 46(10):760-789.
|
[10] |
NILSSON-EHLE H, JAGENBURG R, LANDAHL S, et al. Blood haemoglobin declines in the elderly:implications for reference intervals from age 70 to 88[J]. Eur J Haematol, 2000, 65(5):297-305.
DOI
URL
|
[11] |
MARIES L, MANITIU I. Diagnostic and prognostic values of B-type natriuretic peptides (BNP) and N-terminal fragment brain natriuretic peptides (NT-pro-BNP)[J]. Cardiovasc J Afr, 2013, 24(7):286-289.
DOI
PMID
|
[12] |
GSECKA A, ROGULA S, SZARPAK, et al. LDL-cholesterol and platelets:insights into their interactions in atherosclerosis[J]. Life (Basel), 2021, 11(1):39.
|
[13] |
LIU F T, HSU D K, ZUBERI R I, et al. Expression and function of galectin-3,a beta-galactoside-binding lectin,in human monocytes and macrophages[J]. Am J Pathol, 1995, 147(4):1016-1028.
|
[14] |
ESFAHANI N S, WU Q, KUMAR N, et al. Aging influences the cardiac macrophage phenotype and function during steady state and during inflammation[J]. Aging Cell, 2021, 20(8):e13438.
|
[15] |
TABAS I, LICHTMAN A H. Monocyte-macrophages and T cells in atherosclerosis[J]. Immunity, 2017, 47(4):621-634.
DOI
PMID
|
[16] |
BEHRADMANESH S, NASRI P. Serum cholesterol and LDL-C in association with level of diastolic blood pressure in type 2 diabetic patients[J]. J Renal Inj Prev, 2012, 1(1):23-26.
|
[17] |
ATHYROS V G, DOUMAS M, IMPRIALOS K P, et al. Diabetes and lipid metabolism[J]. Hormones (Athens), 2018, 17(1):61-67.
DOI
PMID
|
[18] |
CASTIGLIONE V, AIMO A, VERGARO G, et al. Biomarkers for the diagnosis and management of heart failure[J]. Heart Fail Rev, 2022, 27(2):625-643.
DOI
|
[19] |
BI J, GARG V, YATES A R. Galectin-3 and sST2 as prognosticators for heart failure requiring extracorporeal life support:Jack n' Jill[J]. Biomolecules, 2021, 11(2):166.
DOI
URL
|
[20] |
唐颖茜. 不同射血分数心衰患者临床及实验室相关指标分析[D]. 昆明: 昆明医科大学, 2017.
|